Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 7Sarcoma, Endometrial Stromal 1Recurrence 1Perivascular Epithelioid Cell Neoplasms 1Endometrial Neoplasms 1ER+ Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Advanced Breast Cancer 1Adenosarcoma of the uterus 1

Interventions

pembrolizumab 71Carboplatin 71Pemetrexed 60Cisplatin 46Nivolumab 30Specimen Handling 29Paclitaxel 29durvalumab 26Magnetic Resonance Spectroscopy 24Docetaxel 23osimertinib 22Gemcitabine 18amivantamab 14Cetuximab 14130-nm albumin-bound paclitaxel 13atezolizumab 12Radiosurgery 12lazertinib 11Ipilimumab 10Ramucirumab 9Radiotherapy 9Bevacizumab 9cemiplimab 8alectinib 8Taxes 8Drug Therapy 8Observation 6Radiation 5Leucovorin 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × elacestrant × 30 days × Clear all
NCT06120283 2026-05-27

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
399 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡